Secondary Prevention Medication Use After Myocardial Infarction in U.S. Nursing Home Residents-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Secondary Prevention Medication Use After Myocardial Infarction in U.S. Nursing Home Residents

Published:2017-10-17 Issue:11 Volume:65 Page:2397-2404
ISSN:0002-8614
Container-title:Journal of the American Geriatrics Society
language:en
Short-container-title:J Am Geriatr Soc

Author:

Zullo Andrew R.¹^ORCID,Sharmin Sadia¹²,Lee Yoojin¹,Daiello Lori A.¹,Shah Nishant R.¹³,John Boscardin W.⁴⁵,Dore David D.¹⁶,Lee Sei J.⁴,Steinman Michael A.⁴

Affiliation:

1. Department of Health Services; Policy; and Practice; School of Public Health; Warren Alpert Medical School; Brown University; Providence Rhode Island

2. Department of Epidemiology; School of Public Health; Warren Alpert Medical School; Brown University; Providence Rhode Island

3. Division of Cardiology; Department of Medicine; Warren Alpert Medical School; Brown University; Providence Rhode Island

4. Division of Geriatrics; University of California; San Francisco and San Francisco Veterans Affairs Medical Center; San Francisco California

5. Division of Biostatistics; University of California, San Francisco; San Francisco California

6. Optum Epidemiology; Boston Massachusetts

Funder

Agency for Healthcare Research and Quality

National Heart, Lung, and Blood Institute

National Institute on Aging

Publisher

Wiley

Subject

Geriatrics and Gerontology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jgs.15144/fullpdf

Reference50 articles.

1. Management and outcomes of ST-elevation myocardial infarction in nursing home versus community-dwelling older patients: A propensity matched study;Khera;J Am Med Dir Assoc,2014

2. Knowledge gaps in cardiovascular care of the older adult population: A scientific statement from the American Heart Association, American College of Cardiology, and American Geriatrics Society;Rich;J Am Coll Cardiol,2016

3. Beta blockade after myocardial infarction: Systematic review and meta regression analysis;Freemantle;BMJ,1999

4. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: Executive summary: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines;O'Gara;Circulation,2013

5. AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: Aguideline from the American Heart Association and American College of Cardiology Foundation;Smith;Circulation,2011

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application and content of minimum data sets for care homes: A mapping review;2024-06-24

2. Association between sociodemographic factors and cholesterol-lowering medication use in U.S. adults post-myocardial infarction;PLOS ONE;2023-02-09

3. Lipid‐lowering treatment among older patients with atherosclerotic cardiovascular disease;Journal of the American Geriatrics Society;2022-12-20

4. Effects and Safety of Sacubitril/Valsartan for Patients with Myocardial Infarction: A Systematic Review and Meta-Analysis;Journal of Healthcare Engineering;2022-01-05

5. Use of health and aged care services in Australia following hospital admission for myocardial infarction, stroke or heart failure;BMC Geriatrics;2021-10-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3